Acknowledgement
Supported by : Chonbuk National University
References
- Albert ML, Darnell RB: Paraneoplastic neurological degenerations: keys to tumour immunity. Nat Rev Cancer 4;36-44, 2004 https://doi.org/10.1038/nrc1255
- Darnell RB, Posner JB: Paraneoplastic syndromes involving the nervous system. N Engl J Med 349;1543-1554, 2003 https://doi.org/10.1056/NEJMra023009
- Darnell RB: Paraneoplastic neurologic disorders: windows into neuronal function and tumor immunity. Arch Neurol 61;30-32, 2004 https://doi.org/10.1001/archneur.61.1.30
- Musunuru K, Darnell RB: Paraneoplastic neurologic disease antigens: RNA-binding proteins and signaling proteins in neuronal degeneration. Annu Rev Neurosci 24;239-262, 2001 https://doi.org/10.1146/annurev.neuro.24.1.239
- Dalmau J, Graus F, Rosenblum MK, Posner JB: Anti-Hu--associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine 71;59-72, 1992 https://doi.org/10.1097/00005792-199203000-00001
- Graus F, Keime-Guibert F, Rene R, Benyahia B, Ribalta T, Ascaso C, Escaramis G, Delattre JY: Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain 124;1138-1148, 2001 https://doi.org/10.1093/brain/124.6.1138
- Denkert C, Weichert W, Pest S, Koch I, Licht D, Kobel M, Reles A, Sehouli J, Dietel M, Hauptmann S: Overexpression of the embryonic-lethal abnormal vision-like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression. Cancer Res 64;189-195, 2004 https://doi.org/10.1158/0008-5472.CAN-03-1987
- Dalmau J, Gultekin HS, Posner JB: Paraneoplastic neurologic syndromes: pathogenesis and physiopathology. Brain Pathol 9;275-284, 1999 https://doi.org/10.1111/j.1750-3639.1999.tb00226.x
- Sutton I, Winer JB: The immunopathogenesis of paraneoplastic neurological syndromes. Clin Sci 102;475-486, 2002 https://doi.org/10.1042/CS20010121
- Dalmau J, Graus F, Cheung NK, Rosenblum MK, Ho A, Canete A, Delattre JY, Thompson SJ, Posner JB: Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer. Cancer 75;99-109, 1995 https://doi.org/10.1002/1097-0142(19950101)75:1<99::AID-CNCR2820750117>3.0.CO;2-I
- Monstad SE, Drivsholm L, Storstein A, Aarseth JH, Haugen M, Lang B, Vincent A, Vedeler CA: Hu and voltage-gated calcium channel (VGCC) antibodies related to the prognosis of small-cell lung cancer. J Clin Oncol 22;795-800, 2004 https://doi.org/10.1200/JCO.2004.01.028
- Chung S, Jiang L, Cheng S, Furneaux H: Purification and properties of HuD, a neuronal RNA-binding protein. J Biol Chem 271;11518-11524, 1996 https://doi.org/10.1074/jbc.271.19.11518
- Levine TD, Gao F, King PH, Andrews LG, Keene JD: Hel-N1: an autoimmune RNA-binding protein with specificity for 3' uridylate-rich untranslated regions of growth factor mRNAs. Mol Cell Biol 13;3494-3504, 1993 https://doi.org/10.1128/MCB.13.6.3494
- Ma WJ, Cheng S, Campbell C, Wright A, Furneaux H: Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein. J Biol Chem 271;8144-8151, 1996 https://doi.org/10.1074/jbc.271.14.8144
- Bevilacqua A, Ceriani MC, Capaccioli S, Nicolin A: Posttranscriptional regulation of gene expression by degradation of messenger RNAs. J Cell Physiol 195;356-372, 2003 https://doi.org/10.1002/jcp.10272
- Chen CY, Shyu AB: AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem Sci 20;465-470, 1995 https://doi.org/10.1016/S0968-0004(00)89102-1
- Guhaniyogi J, Brewer G: Regulation of mRNA stability in mammalian cells. Gene 265;11-23, 2001 https://doi.org/10.1016/S0378-1119(01)00350-X
- Mignone F, Gissi C, Liuni S, Pesole G: Untranslated regions of mRNAs. Genome Biol 3;reviews0004.1-0004.10, 2002
- Shaw G, Kamen R: A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46;659-667, 1986 https://doi.org/10.1016/0092-8674(86)90341-7
- Shim J, Karin M: The control of mRNA stability in response to extracellular stimuli. Mol Cells 14;323-331, 2002
- Bakheet T, Frevel M, Williams BR, Greer W, Khabar KS: ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins. Nucleic Acids Res 29;246-254, 2001 https://doi.org/10.1093/nar/29.1.246
- Blackshear PJ: Tristetraprolin and other CCCH tandem zincfinger proteins in the regulation of mRNA turnover. Biochem Soc Trans 30;945-952, 2002 https://doi.org/10.1042/BST0300945
- Brennan CM, Steitz JA: HuR and mRNA stability. Cell Mol Life Sci 58;266-277, 2001 https://doi.org/10.1007/PL00000854
- Chen CY, Gherzi R, Ong SE, Chan EL, Raijmakers R, Pruijn GJ, Stoecklin G, Moroni C, Mann M, Karin M: AU binding proteins recruit the exosome to degrade ARE-containing mRNAs. Cell 107;451-464, 2001 https://doi.org/10.1016/S0092-8674(01)00578-5
- Gherzi R, Lee KY, Briata P, Wegmuller D, Moroni C, Karin M, Chen CY: A KH domain RNA binding protein, KSRP, promotes ARE-directed mRNA turnover by recruiting the degradation machinery. Mol Cell 14;571-583, 2004 https://doi.org/10.1016/j.molcel.2004.05.002
- Sarkar B, Xi Q, He C, Schneider RJ: Selective degradation of AU-rich mRNAs promoted by the p37 AUF1 protein isoform. Mol Cell Biol 23;6685-6693, 2003 https://doi.org/10.1128/MCB.23.18.6685-6693.2003
- Stoecklin G, Colombi M, Raineri I, Leuenberger S, Mallaun M, Schmidlin M, Gross B, Lu M, Kitamura T, Moroni C: Functional cloning of BRF1, a regulator of ARE-dependent mRNA turnover. EMBO J 21;4709-4718, 2002 https://doi.org/10.1093/emboj/cdf444
- Wilson GM, Brewer G: The search for trans-acting factors controlling messenger RNA decay. Prog Nucleic Acid Res Mol Biol 62:257-91.;257-291, 1999
- Keene JD, Tenenbaum SA: Eukaryotic mRNPs may represent posttranscriptional operons. Mol Cell 9;1161-1167, 2002 https://doi.org/10.1016/S1097-2765(02)00559-2
- Tenenbaum SA, Carson CC, Lager PJ, Keene JD: Identifying mRNA subsets in messenger ribonucleoprotein complexes by using cDNA arrays. Proc Natl Acad Sci USA 97;14085-14090, 2000 https://doi.org/10.1073/pnas.97.26.14085
- Brown V, Jin P, Ceman S, Darnell JC, O'Donnell WT, Tenenbaum SA, Jin X, Feng Y, Wilkinson KD, Keene JD, Darnell RB, Warren ST: Microarray identification of FMRPassociated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell 107;477-487, 2001 https://doi.org/10.1016/S0092-8674(01)00568-2
- Darnell JC, Jensen KB, Jin P, Brown V, Warren ST, Darnell RB: Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell 107;489-499, 2001 https://doi.org/10.1016/S0092-8674(01)00566-9
- Lopez dS, I, Zhan M, Lal A, Yang X, Gorospe M: Identification of a target RNA motif for RNA-binding protein HuR. Proc Natl Acad Sci USA 101;2987-2992, 2004 https://doi.org/10.1073/pnas.0306453101
- Wu Z, Wu J, Jacinto E, Karin M: Molecular cloning and characterization of human JNKK2, a novel Jun NH2-terminal kinase-specific kinase. Mol Cell Biol 17;7407-7416, 1997 https://doi.org/10.1128/MCB.17.12.7407
- Tenenbaum SA, Lager PJ, Carson CC, Keene JD: Ribonomics: identifying mRNA subsets in mRNP complexes using antibodies to RNA-binding proteins and genomic arrays. Methods 26;191-198, 2002 https://doi.org/10.1016/S1046-2023(02)00022-1
- Fan XC, Steitz JA: Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. EMBO J 17;3448-3460, 1998 https://doi.org/10.1093/emboj/17.12.3448
- Ford LP, Watson J, Keene JD, Wilusz J: ELAV proteins stabilize deadenylated intermediates in a novel in vitro mRNA deadenylation/degradation system. Genes Dev 13;188-201, 1999 https://doi.org/10.1101/gad.13.2.188
- Peng SS, Chen CY, Xu N, Shyu AB: RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein. EMBO J 17;3461-3470, 1998 https://doi.org/10.1093/emboj/17.12.3461
- Tenenbaum SA, Carson CC, Atasoy U, Keene JD: Genomewide regulatory analysis using en masse nuclear run-ons and ribonomic profiling with autoimmune sera. Gene 317;79-87, 2003 https://doi.org/10.1016/S0378-1119(03)00661-9